Home › Clinical Tools › Lesion Comparison

📊 Lesion Follow-up Comparison (change, doubling time, RECIST target response)

UseOncology follow-up, response assessment and re-checks of incidental lesions.

Loading calculator…

SourceEisenhauer EA, et al. Eur J Cancer 2009;45:228-247 (RECIST 1.1)

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

PR: ≥30% decrease from baseline.

When to use

Oncology follow-up, response assessment and re-checks of incidental lesions.

How it works

Change = (current − baseline)/baseline; PR ≤ −30% vs baseline; PD ≥ +20% vs nadir and ≥5 mm; doubling time ≈ Δt·ln2 / [3·ln(D2/D1)].

Key points

  • PR: ≥30% decrease from baseline.
  • PD: ≥20% and ≥5 mm increase from nadir.
  • Nodes measured in short axis.
  • Assess non-target and new lesions separately.

References

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Lesion 1 baseline32 mm
Lesion 1 current24 mm
Baseline-to-current interval (for doubling time; optional)84 days

→Target response (RECIST 1.1)SD

  • Lesion 1:32 → 24 mm (-8.0 mm, -25.0%)
  • Sum of diameters:baseline 32.0 / nadir 32.0 / current 24.0 mm
  • vs baseline / vs nadir:-25.0% / -25.0%
Verification & sources · governance
FAQ

Frequently asked questions

What are the limits and cautions when using Lesion Follow-up Comparison (change, doubling time, RECIST target response)?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Lesion Follow-up Comparison (change, doubling time, RECIST target response) upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Lesion Follow-up Comparison (change, doubling time, RECIST target response) calculated in practice? Can you show a worked example?
Inputs: Lesion 1 baseline 32 mm, Lesion 1 current 24 mm, Baseline-to-current interval (for doubling time; optional) 84 days → Result: Target response (RECIST 1.1) SD(Lesion 1: 32 → 24 mm (-8.0 mm, -25.0%), Sum of diameters: baseline 32.0 / nadir 32.0 / current 24.0 mm, vs baseline / vs nadir: -25.0% / -25.0%)
Related tools